COMMUNIQUÉS West-GlobeNewswire

Exactus One World, LLC. Digs in for Initial Cultivation of 200 Acres in Southwest Oregon
13/05/2019
Cultivating the future of the area and industry, one seedling at a time, bringing CBD from the farm to the family DELRAY BEACH, Fla., May 13, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) (the “Company”), is [...]
Blueberries Receives Approval to Sell Five CBD Wellness Products in Colombia and Internationally from Colombian Food and Drug Regulator
13/05/2019
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and cannabis- [...]
Arch Therapeutics, Inc. $2.8 Million Registered Direct Offering
13/05/2019
FRAMINGHAM, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH)(“Arch” or the “Company”), a developer of novel liquid, gel and solid hemostatic and wound care devices, today announced the [...]
Aleafia Health Reports First Quarter 2019 Results, Provides Corporate Update
13/05/2019
• Year-Over-Year Revenue Increases by 1,723% • Licence Applications for Niagara Greenhouse, Port Perry Outdoor now Under Review TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: [...]
Metacrine to Present Relevance of FXR and Specific FXR Drug Profiles for Possible Treatment of Inflammatory Bowel Disease at Digestive Disease Week 2019
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, [...]
Kiniksa Presents Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
13/05/2019
- Data strengthen the scientific evidence for targeting OSMRβ and dual pathway inhibition of IL-31 and OSM via KPL-716 for the potential treatment of chronic pruritic diseases HAMILTON, Bermuda, May 13, 2019 (GLOBE [...]
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
13/05/2019
Onconova to Receive $4 Million Upfront, including $2 Million Fee and $2 Million for Onconova Shares Purchased at a Premium, Plus up to $45.5 Million in Regulatory and Sales Milestones for Rigosertib in Greater China [...]
Avenue Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights
13/05/2019
Safety study completed; Expect to report data from 2nd pivotal Phase 3 trial by the end of second quarter 2019 NEW YORK, May 13, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company [...]
Unum Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
13/05/2019
- Advancing ACTR Clinical Programs in Non-Hodgkin Lymphoma, Multiple Myeloma, and HER2+ Advanced Cancers Through Dose Escalation Studies with Data Expected from All Four Ongoing Trials in Second Half of 2019 - - [...]
Microbix Reports Results for Q2 Fiscal 2019
13/05/2019
Record Sales of $4.25 Million, Sales Growth of 42%, and Material Net Earnings TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and [...]
G1 Therapeutics to Present at UBS Global Healthcare Conference
13/05/2019
RESEARCH TRIANGLE PARK, N.C., May 13, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will present [...]
Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
13/05/2019
– Completed enrollment in Phase 2 studies of praliciguat in diabetic nephropathy and heart failure with preserved ejection fraction (HFpEF) – – Based on encouraging tolerability data, company intends to add a higher [...]
Trillium Therapeutics Reports First Quarter 2019 Financial Results
13/05/2019
TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial [...]
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update
13/05/2019
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare [...]
BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders
13/05/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, May 13, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Catalyst Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
13/05/2019
-Firdapse® Launch Off to Strong Start with First Quarter Net Revenues of $12.4 Million -81 Patients Without Previous Access to any Form of Amifampridine Have Been Prescribed Firdapse -Company to Host Quarterly [...]
Arcoma AB Mattias Rundgren utses till Business Controller för Arcoma
13/05/2019
Arcoma AB (publ) har tillsatt Mattias Rundgren som Business Controller, from den 1:a augusti 2019. Mattias har en civilekonomexamen från Linnéuniversitetet i Växjö och en Bachelor of Arts i Theatre Arts från California [...]
Saniona forms PWS Scientific Advisory Board and provides update on ongoing study
13/05/2019
PRESS RELEASE May 13, 2019 · Scientific Advisory Board (SAB) established for Tesomet in Prader Willi Syndrome Tesomet 0.25 mg/day extension study ongoing in Czech Republic and Hungary Saniona (OMX: SANION), a biotech [...]
EssilorLuxottica: EssilorLuxottica and Delfin sign settlement agreement to solve EssilorLuxottica’s governance issues and unlock the Group’s potential to accelerate the integration process
13/05/2019
EssilorLuxottica and Delfin sign settlement agreement to solve EssilorLuxottica’s governance issues and unlock the Group’s potential to accelerate the integration process Leonardo Del Vecchio and Hubert Sagnières [...]

Pages